Product Pipeline

Products

Oakrum Pharma’s current pipeline consists of active development projects that will serve a total addressable U.S. retail market in excess of $450M dollars, according to IQVIA™, for the 12 months ended December 2018.

Drug
Oak-001
Oak-002
Oak-003
Oak-004
Oak-005
Oak-006
Form Stage of Development Expected Launch Date
Foam In Development Q3 2020
Powder In Development Q4 2020
Oral Suspension In Development Q4 2020
Powder In Development Q4 2020
Tablet In Development Q3 2021
Capsule In Development Q3 2021